Janux Therapeutics, Inc. (JANX) Tops Q4 EPS by 11c

Janux Therapeutics, Inc. (NASDAQ: JANX) reported Q4 EPS of ($0.51), $0.11 better than the analyst estimate of ($0.62).

For earnings history and earnings-related data on Janux Therapeutics, Inc. (JANX) click here.

You May Also Be Interested In

• Corning (GLW) files for up to $2B offering of common shares
• Boeing wins $13.4 billion contract modification from US military
• Goldman, BofA vie to manage Anthropic employee wealth post-IPO - report